AAAAAA

   
Results: 1-23 |
Results: 23
IMMUNOLOGICAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTES AND PERIPHERAL-BLOOD LYMPHOCYTES IN OVARIAN-CANCER PATIENTS
Authors: SCHONDORF T ENGEL H KURBACHER CM BRENNE U KOLHAGEN H GOHRING UJ SCHARL A MALLMANN P
Citation: T. Schondorf et al., IMMUNOLOGICAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTES AND PERIPHERAL-BLOOD LYMPHOCYTES IN OVARIAN-CANCER PATIENTS, Journal of the Society for Gynecologic Investigation, 5(2), 1998, pp. 102-107
USE OF AN EX-VIVO ATP LUMINESCENCE ASSAY TO DIRECT CHEMOTHERAPY FOR RECURRENT OVARIAN-CANCER
Authors: KURBACHER CM CREE IA BRUCKNER HW BRENNE U KURBACHER JA MULLER K ACKERMANN T GILSTER TJ WILHELM LM ENGEL H MALLMANN PK ANDREOTTI PE
Citation: Cm. Kurbacher et al., USE OF AN EX-VIVO ATP LUMINESCENCE ASSAY TO DIRECT CHEMOTHERAPY FOR RECURRENT OVARIAN-CANCER, Anti-cancer drugs, 9(1), 1998, pp. 51-57
COMBINATION CHEMOTHERAPY FOR CHOROIDAL MELANOMA - EX-VIVO SENSITIVITYTO TREOSULFAN WITH GEMCITABINE OR CYTOSINE-ARABINOSIDE
Authors: CREE IA NEALE M MYATT N HUNGERFORD JL KURBACHER CM
Citation: Ia. Cree et al., COMBINATION CHEMOTHERAPY FOR CHOROIDAL MELANOMA - EX-VIVO SENSITIVITYTO TREOSULFAN WITH GEMCITABINE OR CYTOSINE-ARABINOSIDE, Annals of oncology, 9, 1998, pp. 638-638
CHEMOPROTECTION IN ANTICANCER THERAPY - THE EMERGING ROLE OF AMIFOSTINE (WR-2721)
Authors: KURBACHER CM MALLMANN PK
Citation: Cm. Kurbacher et Pk. Mallmann, CHEMOPROTECTION IN ANTICANCER THERAPY - THE EMERGING ROLE OF AMIFOSTINE (WR-2721), Anticancer research, 18(3C), 1998, pp. 2203-2210
DETECTION OF CHROMOSOMAL-ABERRATIONS IN TUMOR-CELLS AND TUMOR-INFILTRATING LYMPHOCYTES BY MOLECULAR CYTOGENETICS IN PATIENTS WITH GYNECOLOGICAL CANCER
Authors: ENGEL H FRIEDRICH T KLEESPIES C KURBACHER CM SCHONDORF T GRECU O KOLHAGEN H MALLMANN P
Citation: H. Engel et al., DETECTION OF CHROMOSOMAL-ABERRATIONS IN TUMOR-CELLS AND TUMOR-INFILTRATING LYMPHOCYTES BY MOLECULAR CYTOGENETICS IN PATIENTS WITH GYNECOLOGICAL CANCER, Cancer genetics and cytogenetics, 106(2), 1998, pp. 159-165
MITOXANTRONE COMBINED WITH PACLITAXEL AS SALVAGE THERAPY FOR PLATINUM-REFRACTORY OVARIAN-CANCER - LABORATORY STUDY AND CLINICAL PILOT TRIAL
Authors: KURBACHER CM BRUCKNER HW CREE IA KURBACHER JA WILHELM L POCH G INDEFREI D MALLMANN P ANDREOTTI PE
Citation: Cm. Kurbacher et al., MITOXANTRONE COMBINED WITH PACLITAXEL AS SALVAGE THERAPY FOR PLATINUM-REFRACTORY OVARIAN-CANCER - LABORATORY STUDY AND CLINICAL PILOT TRIAL, Clinical cancer research, 3(9), 1997, pp. 1527-1533
DOSE-RESPONSE IN PRIMARY OVARIAN-CANCER EVALUATED BY AN EX-VIVO ATP CHEMOSENSITIVITY ASSAY
Authors: KURBACHER CM MUNSCH S BRENNE U GILSTER T MALLMANN P BRUCKNER HW
Citation: Cm. Kurbacher et al., DOSE-RESPONSE IN PRIMARY OVARIAN-CANCER EVALUATED BY AN EX-VIVO ATP CHEMOSENSITIVITY ASSAY, European journal of cancer, 33, 1997, pp. 539-539
EVIDENCE OF P53-INDEPENDENT ACTIVATION OF BCL-2 IN ADVANCED OVARIAN AND ENDOMETRIUM CARCINOMAS
Authors: GILSTER TJ KURBACHER CM GOOR A JANAT M BECKER M ENGEL H MALLMANN P
Citation: Tj. Gilster et al., EVIDENCE OF P53-INDEPENDENT ACTIVATION OF BCL-2 IN ADVANCED OVARIAN AND ENDOMETRIUM CARCINOMAS, European journal of cancer, 33, 1997, pp. 548-548
CORRELATION BETWEEN BCL-2 EXPRESSION AND EX-VIVO CHEMOSENSITIVITY OF ADVANCED GYNECOLOGIC CANCERS
Authors: LANDSBERG D ENGEL H KURBACHER CM KOLHAGEN H MALLMANN P
Citation: D. Landsberg et al., CORRELATION BETWEEN BCL-2 EXPRESSION AND EX-VIVO CHEMOSENSITIVITY OF ADVANCED GYNECOLOGIC CANCERS, European journal of cancer, 33, 1997, pp. 788-788
THE EX-VIVO CHEMOSENSITIVITY PROFILE OF CHOROIDAL MELANOMA
Authors: MYATT N CREE IA KURBACHER CM FOSS AJE HUNGERFORD JL PLOWMAN PN
Citation: N. Myatt et al., THE EX-VIVO CHEMOSENSITIVITY PROFILE OF CHOROIDAL MELANOMA, Anti-cancer drugs, 8(8), 1997, pp. 756-762
INDIVIDUALIZING CHEMOTHERAPY FOR SOLID TUMORS - IS THERE ANY ALTERNATIVE
Authors: CREE IA KURBACHER CM
Citation: Ia. Cree et Cm. Kurbacher, INDIVIDUALIZING CHEMOTHERAPY FOR SOLID TUMORS - IS THERE ANY ALTERNATIVE, Anti-cancer drugs, 8(6), 1997, pp. 541-548
CORRELATION OF THE CLINICAL-RESPONSE TO CHEMOTHERAPY IN BREAST-CANCERWITH EX-VIVO CHEMOSENSITIVITY
Authors: CREE IA KURBACHER CM UNTCH M SUTHERLAND LA HUNTER EM SUBEDI AMC JAMES EA DEWAR JA PREECE PE ANDREOTTI PE BRUCKNER HW
Citation: Ia. Cree et al., CORRELATION OF THE CLINICAL-RESPONSE TO CHEMOTHERAPY IN BREAST-CANCERWITH EX-VIVO CHEMOSENSITIVITY, Anti-cancer drugs, 7(6), 1996, pp. 630-635
ASCORBIC-ACID (VITAMIN-C) IMPROVES THE ANTINEOPLASTIC ACTIVITY OF DOXORUBICIN, CISPLATIN, AND PACLITAXEL IN HUMAN BREAST-CARCINOMA CELLS IN-VITRO
Authors: KURBACHER CM WAGNER U KOLSTER B ANDREOTTI PE KREBS D BRUCKNER HW
Citation: Cm. Kurbacher et al., ASCORBIC-ACID (VITAMIN-C) IMPROVES THE ANTINEOPLASTIC ACTIVITY OF DOXORUBICIN, CISPLATIN, AND PACLITAXEL IN HUMAN BREAST-CARCINOMA CELLS IN-VITRO, Cancer letters, 103(2), 1996, pp. 183-189
HETEROGENEITY OF IN-VITRO CHEMOSENSITIVITY IN PERIOPERATIVE BREAST-CANCER CELLS TO MITOXANTRONE VERSUS DOXORUBICIN EVALUATED BY A MICROPLATE ATP BIOLUMINESCENCE ASSAY
Authors: KURBACHER CM CREE IA BRENNE U BRUCKNER HW KURBACHER JA MALLMANN P ANDREOTTI PE KREBS D
Citation: Cm. Kurbacher et al., HETEROGENEITY OF IN-VITRO CHEMOSENSITIVITY IN PERIOPERATIVE BREAST-CANCER CELLS TO MITOXANTRONE VERSUS DOXORUBICIN EVALUATED BY A MICROPLATE ATP BIOLUMINESCENCE ASSAY, Breast cancer research and treatment, 41(2), 1996, pp. 161-170
CHEMOSENSITIVITY TESTING IN GYNECOLOGICAL ONCOLOGY - EXPERIENCES WITHAN ATP-BIOLUMINESCENCE ASSAY
Authors: KURBACHER CM MALLMANN P KURBACHER JA HUBNER H KREBS D
Citation: Cm. Kurbacher et al., CHEMOSENSITIVITY TESTING IN GYNECOLOGICAL ONCOLOGY - EXPERIENCES WITHAN ATP-BIOLUMINESCENCE ASSAY, Geburtshilfe und Frauenheilkunde, 56(2), 1996, pp. 70-78
TUMOR CHEMOSENSITIVITY AND CHEMORESISTANCE ASSAYS
Authors: CREE LA PETTY RD KURBACHER CM UNTCH M
Citation: La. Cree et al., TUMOR CHEMOSENSITIVITY AND CHEMORESISTANCE ASSAYS, Cancer, 78(9), 1996, pp. 2031-2032
INFLUENCE OF HUMAN LUTEINIZING-HORMONE ON CELL-GROWTH AND CA-125 SECRETION OF PRIMARY EPITHELIAL OVARIAN CARCINOMAS IN-VITRO
Authors: KURBACHER CM JAGER W KURBACHER JA BITTL A WILDT L LANG N
Citation: Cm. Kurbacher et al., INFLUENCE OF HUMAN LUTEINIZING-HORMONE ON CELL-GROWTH AND CA-125 SECRETION OF PRIMARY EPITHELIAL OVARIAN CARCINOMAS IN-VITRO, Tumor biology, 16(6), 1995, pp. 374-384
IN-VITRO ACTIVITY OF TITANOCENEDICHLORIDE VERSUS CISPLATIN IN 4 OVARIAN-CARCINOMA CELL-LINES EVALUATED BY A MICROTITER PLATE ATP BIOLUMINESCENCE ASSAY
Authors: KURBACHER CM BRUCKNER HW ANDREOTTI PE KURBACHER JA SASS G KREBS D
Citation: Cm. Kurbacher et al., IN-VITRO ACTIVITY OF TITANOCENEDICHLORIDE VERSUS CISPLATIN IN 4 OVARIAN-CARCINOMA CELL-LINES EVALUATED BY A MICROTITER PLATE ATP BIOLUMINESCENCE ASSAY, Anti-cancer drugs, 6(5), 1995, pp. 697-704
CHEMOSENSITIVITY TESTING OF HUMAN TUMORS USING A MICROPLATE ADENOSINE-TRIPHOSPHATE LUMINESCENCE ASSAY - CLINICAL CORRELATION FOR CISPLATIN RESISTANCE OF OVARIAN-CARCINOMA
Authors: ANDREOTTI PE CREE IA KURBACHER CM HARTMANN DM LINDER D HAREL G GLEIBERMAN I CARUSO PA RICKS SH UNTCH M SARTORI C BRUCKNER HW
Citation: Pe. Andreotti et al., CHEMOSENSITIVITY TESTING OF HUMAN TUMORS USING A MICROPLATE ADENOSINE-TRIPHOSPHATE LUMINESCENCE ASSAY - CLINICAL CORRELATION FOR CISPLATIN RESISTANCE OF OVARIAN-CARCINOMA, Cancer research, 55(22), 1995, pp. 5276-5282
IN-VITRO ACTIVITY OF TITANOCENEDICHLORIDE VERSUS CISPLATIN AND DOXORUBICIN IN PRIMARY AND RECURRENT EPITHELIAL OVARIAN-CANCER
Authors: KURBACHER CM MALLMANN P KURBACHER JA SASS G ANDREOTTI PE RAHMUN A HUBNER H KREBS D
Citation: Cm. Kurbacher et al., IN-VITRO ACTIVITY OF TITANOCENEDICHLORIDE VERSUS CISPLATIN AND DOXORUBICIN IN PRIMARY AND RECURRENT EPITHELIAL OVARIAN-CANCER, Anticancer research, 14(5A), 1994, pp. 1961-1965
IN-VITRO ACTIVITY OF TITANOCENEDICHLORIDE IN HUMAN RENAL-CELL CARCINOMA COMPARED TO CONVENTIONAL ANTINEOPLASTIC AGENTS
Authors: KURBACHER CM NAGEL W MALLMANN P KURBACHER JA SASS G HUBNER H ANDREOTTI PE KREBS D
Citation: Cm. Kurbacher et al., IN-VITRO ACTIVITY OF TITANOCENEDICHLORIDE IN HUMAN RENAL-CELL CARCINOMA COMPARED TO CONVENTIONAL ANTINEOPLASTIC AGENTS, Anticancer research, 14(4A), 1994, pp. 1529-1533
DISSEMINATED BONE-MARROW METASTASES FROM PRIMARY BREAST-CANCER - DETECTION AND FOLLOW-UP BY RADIOIMMUNE BONE-MARROW SCINTIGRAPHY
Authors: RIEKER O GRUNWALD F LAYER G KURBACHER CM HOTZE AL MENZEL C BIERSACK HJ
Citation: O. Rieker et al., DISSEMINATED BONE-MARROW METASTASES FROM PRIMARY BREAST-CANCER - DETECTION AND FOLLOW-UP BY RADIOIMMUNE BONE-MARROW SCINTIGRAPHY, The Journal of nuclear medicine, 35(9), 1994, pp. 1485-1487
MONOLAYER CELL-CULTURES FOR DETERMINATION OF EXTRAGENITAL TUMOR-CELL DISSEMINATION IN OVARIAN-CANCER
Authors: KURBACHER CM ATANASOV N KURBACHER JA BREUEL C JAGER W LANG N
Citation: Cm. Kurbacher et al., MONOLAYER CELL-CULTURES FOR DETERMINATION OF EXTRAGENITAL TUMOR-CELL DISSEMINATION IN OVARIAN-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1055-1056
Risultati: 1-23 |